Consequential late effects up to >10 years following primary and postoperative radiotherapy for prostate cancer

Radiother Oncol. 2021 Mar:156:188-192. doi: 10.1016/j.radonc.2020.12.017. Epub 2020 Dec 24.

Authors

Friederike Leufgens¹, Amr Gharib¹, Marsha Schlenter¹, Ludmila Timm², Michael Pinkawa³

Affiliations

¹ Department of Radiation Oncology, RWTH Aachen University, Aachen, Germany.
² Department of Radiation Oncology, RWTH Aachen University, Aachen, Germany; Department of Radiation Oncology, MediClin Robert Janker Klinik, Bonn, Germany.
³ Department of Radiation Oncology, RWTH Aachen University, Aachen, Germany; Department of Radiation Oncology, MediClin Robert Janker Klinik, Bonn, Germany. Electronic address: michael.pinkawa@post.rwth-aachen.de.

PMID: 33358772
DOI: 10.1016/j.radonc.2020.12.017

No abstract available

MeSH terms

Disease Progression
Humans
Male
Prostatic Neoplasms* / radiotherapy
Prostatic Neoplasms* / surgery
Radiotherapy Dosage